Academic Initiative

Academic Programmes

Pharmacotherapy of POCS with reference to obesity – CME by Novo

5 July, 2026

Academic Programmes

One Choice, Multiple Wins: Semaglutide as First-Line Therapy in T2D – CME by Novo

30 June, 2026

Academic Programmes

Beyond GLP-1 RAs: Mounjaro – A Class of Its Own – CME by Lilly

29 June, 2026

Academic Programmes

From Base to Peak: Approaching the Obesity Mountain with Tirzepatide – CME by Cipla

27 June, 2026

Academic Programmes

From Glycemic Challenges to Practical Solutions – CME by Eris

26 June, 2026

Academic Programmes

Innovator Semaglutide 2.4 mg: A Benchmark Therapy for Chronic Weight Management – CME by Novo (Wegovy)

23 June, 2026

Academic Programmes

Advancing T2DM Management with Innovative Fixed Ratio Combination – CME by Sanofi

22 June, 2026

Academic Programmes

Healthy Aging: How to Stay Independent, Active & Sharp After 60 – Yoga Day Health Talk

21 June, 2026

Academic Programmes

PANEL DISCUSSION: PRACTICAL INSIGHTS & MYTHS VS FACTS ON SEMAGLUTIDE ROLE: PANELIST – HAD 2026, NAGPUR

20 June, 2026

Academic Programmes

The Decade of Metabolic Renaissance – DCTCON 2026, TRICHY

13 June, 2026

Academic Programmes

Ozempic Evidence Dialogue – CME by Novo

5 June, 2026

Academic Programmes

Mounjaro: A Unified Strategy for Metabolic Disease – CME by Lilly

30 May, 2026